EPHE

Ephe is a New York-based biotechnology company focused on the development of programmable medicines. The company's platform leverages RNA-mediated technologies and functional genomics to precisely regulate gene expression. Founded by Siddharth Venkatesh and Neville Sanjana, Ephe aims to create a modular therapeutic system capable of addressing a wide range of indications, including oncology and genetic disorders. The company is currently in the early stages of platform development and is operating primarily in stealth mode. Ephe's approach combines advanced computational biology with novel molecular engineering to design highly specific and programmable therapeutic candidates.